Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome

Gynecologic and Obstetric Investigation

Volumn 78, Issue 1, 2014, Pages 41-44

  Lin, Min ^a   Xu, Xiaowen ^a   Wang, Yi ^a   Hu, Yue ^a   Zhao, Yu ^a  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Endometrial hyperplasia; Levonorgestrel releasing intrauterine system; Polycystic ovary syndrome

Indexed keywords

HEMOGLOBIN; LEVONORGESTREL; MIFEPRISTONE; PROGESTERONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ASSESSMENT TOOL; CURETTAGE; DRUG USE; ENDOMETRIAL THICKNESS; ENDOMETRIUM HYPERPLASIA; EVALUATION STUDY; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; MENSTRUATION; MENSTRUATION DISORDER; OVARY POLYCYSTIC DISEASE; PICTORIAL BLOOD ASSESSMENT CHART; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; VAGINA BLEEDING; COMPLICATION; ENDOMETRIAL HYPERPLASIA; FEMALE; INTRAUTERINE CONTRACEPTIVE DEVICE; PATHOLOGY; ANEMIA; RELAPSE; REMISSION;

ENDOMETRIAL HYPERPLASIA; FEMALE; HEMOGLOBINS; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENSTRUATION; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME;

EID: 84904391248     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000362275     Document Type: Article

References (12)

1. Badawy A, Elnashar A: Treatment options for polycystic ovary syndrome. Int J Womens Health 2011; 3:25-35.
2. Macut D, Pfeifer M, Yildiz BO, Diamanti-Kandarakis E (eds): Polycystic ovary syndrome. Novel insights into causes and therapy. Front Horm Res. Basel, Karger, 2013, vol 40, pp 1-21.
3. Ewies AA, Alfhaily F: Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperpla-sia. Obstet Gynecol Surv 2012; 67:726-733.
4. Azziz R: Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005; 83:1343-1346. (Pubitemid 40615803)
5. Higham JM, O'Brien PM, Shaw RW: Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynccol 1990; 97:734-739. (Pubitemid 20263124)
6. Zakherah MS, Sayed GH, El-Nashar SA, Sha-aban MM: Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding. Gynecol Obstet Invest 2011; 71:281-284.
7. Park JC, Lim SY, Jang TK, et al: Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome. Clin Exp Reprod Med 2011; 38:42-46.
8. Dumesic DA, Lobo RA: Cancer risk and PCOS. Steroids 2013; 78:782-785.
9. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S: Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009; 19:398-405.
10. Haoula Z, Salman M, Atiomo W: Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27:1327-1331.
11. Hubbs JL, Saig RM, Abaid LN, Bae-Jump VL, Gehrig PA: Systemic and local hormone therapy for endometrial hyperplasia and early ad-enocarcinoma. Obstet Gynecol 2013; 121: 1172-1180.
12. Minig L, Franchi D, Valero de Bernabé J, Sid-eri M: Controversies of the hormonal conservative treatment of endometrial cancer. Gy-necol Obstet Invest 2013; 75:145-151.